COVID-19 Prevention
Showing 1 - 25 of >10,000
Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection, COVID-19 Trial (Nirmatrelvir/ritonavir, Placebo)
Not yet recruiting
- Post COVID-19 Condition, Unspecified
- +2 more
- Nirmatrelvir/ritonavir
- Placebo
- (no location specified)
May 9, 2023
COVID-19 Trial in Calgary (Persuasive Appeal)
Completed
- COVID-19
- Persuasive Appeal
-
Calgary, Alberta, CanadaLucid Marketplace
Feb 8, 2023
COVID-19 Trial (Education, Motivational)
Not yet recruiting
- COVID-19
- Education
- Motivational
- (no location specified)
Aug 11, 2022
Covid19 Trial in Toronto, Mumbai, Bangkok (eHealth for Covid-19 prevention and support)
Recruiting
- Covid19
- eHealth for Covid-19 prevention and support
-
Toronto, Ontario, Canada
- +2 more
May 23, 2022
COVID-19 Trial (GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile))
Not yet recruiting
- COVID-19
- GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile)
- (no location specified)
Oct 4, 2023
COVID-19, Upper Respiratory Tract Infections Trial in Sofia (TaffiX™)
Completed
- COVID-19
- Upper Respiratory Tract Infections
- TaffiX™
-
Sofia, BulgariaDiagnostics and Consultation Center Convex Ltd
Feb 23, 2022
COVID-19 Respiratory Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Pamplona (Nasal Photodisinfection, Sham
Completed
- COVID-19 Respiratory Infection
- SARS-CoV-2 Acute Respiratory Disease
- Nasal Photodisinfection
- Sham Comparator: Control
-
Pamplona, SpainClinica Universidad de Navarra
Aug 10, 2022
COVID-19 Trial ("Sputnik Lite" vaccine for the prevention of COVID-19 with altered antigenic composition)
Not yet recruiting
- COVID-19
- "Sputnik Lite" vaccine for the prevention of COVID-19 with altered antigenic composition
- (no location specified)
Sep 26, 2023
COVID-19 Trial in Sofia (Ivermectin Tablets, Matching tablets)
Recruiting
- COVID-19
- Ivermectin Tablets
- Matching placebo tablets
-
Sofia, BulgariaMedical Center Medic Ltd.
Mar 30, 2022
COVID-19 Pandemics, Human Immunodeficiency Virus Trial in Taipei
Recruiting
- COVID-19 Pandemics
- Human Immunodeficiency Virus
-
Taipei, TaiwanSchool of Nursing of National Taiwan University
Jan 25, 2022
COVID-19 Trial (GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition)
Not yet recruiting
- COVID-19
- GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition
- (no location specified)
Oct 4, 2023
Evaluation Study Trial in Lusaka (BEHAVIOURAL CHANGE CAMPAIGN FOR COVID-19 PREVENTION IN ZAMBIA)
Completed
- Evaluation Study
- BEHAVIOURAL CHANGE CAMPAIGN FOR COVID-19 PREVENTION IN ZAMBIA
-
Lusaka, ZambiaCentre for Infectious Disease Research in Zambia
Nov 11, 2021
SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)
Recruiting
- SARS-CoV-2 Infection
- COVID-19 mRNA Vaccine (ZSVG-02-O)
- COVID-19 Vaccine (Vero Cell) ,Inactivated
-
Dengfeng, Henan, China
- +1 more
Nov 6, 2023
Knowledge, Attitudes, Practice, Covid19 Trial in Toronto (Kukaa Salama: mHealth intervention, Face Mask + Soap)
Completed
- Knowledge, Attitudes, Practice
- Covid19
- Kukaa Salama: mHealth intervention
- Face Mask + Soap
-
Toronto, Ontario, CanadaFactor-Inwentash Faculty of Social Work, University of Toronto
Dec 23, 2021
Covid-19, Respiratory Tract Infections Trial in Oslo (Cod liver oil, Corn oil ())
Completed
- Covid-19
- Respiratory Tract Infections
- Cod liver oil
- Corn oil (placebo)
-
Oslo, NorwayOslo University Hospital
Mar 28, 2022
COVID-19 Trial in Beijing (SA55 Injection, Placebo for SA55 injection)
Recruiting
- COVID-19
- SA55 Injection
- Placebo for SA55 injection
-
Beijing, ChinaBeijing Ditan Hospital Capital Medical University
Sep 20, 2023
Post COVID-19 Condition, Long COVID Trial in Zürich (Pycnogenol®, Placebo)
Recruiting
- Post COVID-19 Condition
- Long COVID
- Pycnogenol®
- Placebo
-
Zürich, SwitzerlandUniversity of Zurich, Epidemiology, Biostatistics and Prevention
Jun 9, 2023
COVID-19 Prevention Trial in Louisville (Q-Griffithsin, Placebo)
Completed
- COVID-19 Prevention
- Q-Griffithsin
- Placebo
-
Louisville, KentuckyUniversity of Louisville
Apr 28, 2022
Prevention of SARS-CoV-2 Secondary Infection Trial in San Diego (COVID Prevention Program (CPP))
Recruiting
- Prevention of SARS-CoV-2 Secondary Infection
- COVID Prevention Program (CPP)
-
San Diego, CaliforniaSan Diego State University Research Foundation
Jan 20, 2023
Covid19, SARS-COV-2 Infection Trial (DWJ1248, Placebo)
Terminated
- Covid19
- SARS-COV-2 Infection
- DWJ1248
- Placebo
-
Seoul, Korea, Republic ofSamsung Medical Center
Dec 4, 2022
COVID-19 Trial in New York (SMARTest mobile app for COVID-19 self-testing)
Recruiting
- COVID-19
- SMARTest mobile app for COVID-19 self-testing
-
New York, New YorkICAP Harlem Prevention Center
Jan 25, 2023
Pulmonary Fibrosis, COVID-19 Pneumonia, Long COVID Trial in Chicago (Sirolimus)
Recruiting
- Pulmonary Fibrosis
- +2 more
-
Chicago, IllinoisUniversity of Chicago
Nov 18, 2022
COVID-19, SARS-CoV2 Infection Trial in New Haven (Neosporin, Vaseline)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Neosporin
- Vaseline
-
New Haven, ConnecticutYale University
Sep 12, 2022
COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))
Recruiting
- COVID-19
- Recombinant new coronavirus vaccine (CHO cell)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Jun 2, 2023
Inactivated COVID-19 Vaccine in Thousands of Autoimmune Diseases
Recruiting
- COVID-19 Vaccines
- Autoimmune Diseases
- the inactivated COVID-19 vaccines
-
Hangzhou, Zhejiang, ChinaThe Affiliated Hospital of Zhejiang Chinese Medicine University
Apr 25, 2023